93results about How to "Maximum capability" patented technology

An implant (1) to be implanted in bone tissue, e.g. a dental implant or an implant for an orthopedic application, comprises surface regions (4) of a first type which have e.g. osseo-integrative, inflammation-inhibiting, infection-combating and/or growth-promoting properties, and surface regions (8) of a second type which consist of a material being liquefiable by mechanical oscillation. The implant is positioned in an opening of e.g. a jawbone and then mechanical oscillations, e.g. ultrasound is applied to it while it is pressed against the bone. The liquefiable material is such liquefied at least partly and is pressed into unevennesses and pores of the surrounding bone tissue where after resolidification it forms a positive-fit connection between the implant and the bone tissue. The surface regions of the two types are arranged and dimensioned such that, during implantation, the liquefied material does not flow or flows only to a clinically irrelevant degree over the surface regions of the first type such enabling the biologically integrative properties of these surface regions to start acting directly after implantation. The implant achieves with the help of the named positive fit a very good (primary) stability, i.e. it can be loaded immediately after implantation. By this, negative effects of non-loading are prevented and relative movements between implant and bone tissue are reduced to physiological measures and therefore have an osseo-integration promoting effect.

A system for designing and monitoring clinical trials includes a main database of information concerning prior clinical trials and resources available to conduct future clinical trials. In part information in the main database is obtained through data links to other databases in the enterprise, e.g., human resources and finance databases. Some of the information in the main database concerns prior clinical trials and is, in part, in the form of protocols of (a) scheduled visits of a test subject to a treatment site, (b) measurement of prescribed physical attributes of the subject during the visits and (c) administration of at least one prescribed medical product to the subject during the visit to determine over time the subject's response thereto. The protocols of prior clinical trial are stored in the main database in the form of a software template.

The invention provides a non-woven fabric comprising at least two separate but interconnected layers, each of the layers being provided with discrete interconnections so as to provide discrete voids between the two layers of fabric.

This invention provides a thin type of noncontact IC tag label that allows materials costs to be reduced without using an antenna-supporting base film. The noncontact IC tag label includes an electroconductive layer 6 of a required antenna pattern shape, an IC chip 3 mounted on one face of the electroconductive layer 6, and a surface protection sheet 4 supporting the electroconductive layer 6 and the IC chip 3 from a side of the one face of the electroconductive layer 6 via a first pressure-sensitive adhesive layer 5. An adhesive resin layer 7 having the same shape as the antenna pattern shape of the electroconductive layer 6 is provided on the other face of the electroconductive layer 6. The adhesive resin layer 7 is temporarily bonded in separable manner onto a release paper 9 formed from paper or a plastic base material.

A voltage regulator includes a linear mode regulator having a high pass filter circuit connected between its output and an output node, and a switch mode regulator having an low pass filter circuit connected between its output and the same output node. The high pass filter passes high frequency AC current provided by the linear mode regulator to the output node and reduces the low frequency AC and DC currents to substantially zero, and the low pass filter prevents the high frequency AC current produced by the linear mode regulator from being drawn by the switch mode regulator and passes the low AC and DC currents provided by the switch mode regulator to the output node. Thus, the present regulator offers the high response speed and low noise of a linear mode regulator, and the high power efficiency and large continuous output current capability of a switch mode regulator.

Provided is a self-optimizing computer system that can achieve ultimate optimization (improvement in the speed) by preparing a mechanism that can observe the behavior of the program execution in the self-optimizing computer system and optimize dynamically depending on the execution behavior of program. The self-optimizing computer system comprising multiple processing units, characterized in that each of the processing units operates as at least one of an operation processing unit for executing a program, an observation processing unit for observing the behavior of the program under execution, an optimization processing unit for performing an optimization process according to the observation result of the observation processing unit, and a resource management processing unit for performing a resource management process of whole of the system such as a change of the contents of execution.

A jet engine nozzle having a pair of pivoting extension arms and a pair of pivoting shells connected to a jet pipe is provided. The first extension arm is pivotally connected to the jet pipe at a first location, while the second extension arm is pivotally connected to the jet pipe at a second location. Each shell is pivotally connected at both the first and second locations. An axis of rotation associated with the first location is coaxial to an axis of rotation associated with the second location. Independent actuation means are provided to rotate the extension arms and the shells, thereby enabling adjustment of the thrust-vector angle or the exhaust area of the nozzle.

The invention relates to a solar photovoltaic energy conversion apparatus. The apparatus consists of a substrate, a buffer layer formed on the substrate layer, a first transparent conductive oxide layer formed on the buffer layer, periodic protrusions containing first silicon layers formed on the first transparent conductive oxide layer, second silicon layers formed on the first silicon layers, a second transparent conductive oxide layer covering the first silicon layers, the second silicon layers and the first transparent conductive oxide layer, and an anti-reflective protective layer. The first silicon layer and the second silicon layer are the electrodes with the opposite type of charge carriers. The first transparent conductive layer and the second transparent conductive layer are the electrodes with the opposite type of charge carriers. This TCO-based hybrid solar photovoltaic energy conversion device not only can allow the transmission of visible sunlight but also can enhance the photovoltaic energy.

A waterless blood heater/cooler device directly controlling temperature of blood flowing through an extracorporeal blood circuit. A thermoelectric module is coupled to a supply voltage to generate a temperature difference. A heat exchanger cassette comprising a core and first and second laminar flow guides is in thermal contact (directly or indirectly) with the thermoelectric module. The cassette has a plurality of tubes for carrying parallel channels of the blood. The first and second laminar flow guides provide an inlet and an outlet for coupling to the extracorporeal blood circuit and respective intermediate chambers for receiving respective ends of the tubes in order to guide the blood to and from respective tubes in a substantially laminar flow.

A closed-loop permanent magnet motor control method and system optimally partitions torque and flux-weakening currents to produce a desired torque without exceeding the capability of the DC source. A maximum limit for allowable torque current and a minimum threshold for the maximum torque current are determined, and the flux current is varied based at least in part on whether the maximum torque current limit is above or below the minimum threshold while operating in a flux-weakening region to compensate for the variability of the DC source voltage.

A moving image generating apparatus comprises: an obtaining device which obtains a series of image data in which high-resolution first image data obtained at a predetermined frame rate and low-resolution second image data obtained at times that are different from the times of the obtainment of the first image data are arranged in a given order; a characteristic point extracting device which extracts characteristic points in the first image data; a corresponding point detecting device which detects corresponding points in the second image data, the corresponding points corresponding to characteristic points in first image data obtained immediately before the second image data; and a generating device which generates high-resolution image data having a content that is the same as that of the second image data by modifying the first image data based on the relationship between the characteristic points extracted by the characteristic point extracting device and the corresponding points detected by the corresponding point detecting device.

A multi-panel monitor displaying system has a multi-panel monitor supported by one integrated Liquid Crystal Display Glass Module (LGM). The multi-panel monitor contains visually un-detective gaps between panels and, therefore, can provide viewers with high quality visual effect with low productive cost. A set of LGM technologies is utilized to re-design and integrate a plurality of LGMs. After integration, image rotation is also required by the multi-monitor displaying system to ensure perfect image displays.

A coating for an article is provided to enhance vibration damping and fatigue strength, without diluting resistance to erosion, wear, and corrosion for metallic components such as blades, blisks, shafts and bearings of a gas turbine engine operating in a hostile environment. The invention includes a metallic substrate and a thin layer of magneto-mechanical material bonded to the surface of the substrate by a coating process. The coating material is made of the Fe—Cr—Al or Fe—Cr—Mo based magneto-mechanical materials and deposited to the surface of the substrate via a thermal spraying process in vacuum or in air. In order to achieve maximum damping capability and resistance to erosion, wear, and corrosion, several optimal compositions of the coating material in conjunction with new application methods have been developed. The coating is often very thin and smooth in order not to dilute aerodynamic efficiency and fatigue strength. The thin layer of magneto-mechanical material can also be applied and bonded to the substrate by a variety of methods, for example using a self-adhesive foil, made by Fe—Cr—Al or Fe—Cr—Mo alloys, on the surface of the substrate and via thermal spraying or physical vapor deposition processes.

The present invention relates generally to the use of plants as bioreactors for the production of molecules having useful properties such as inter alia polymers, metabolites, proteins, pharmaceuticals and nutraceuticals. More particularly, the present invention contemplates the use of grasses, and even more particularly C4 grasses, such as sugar-cane, for the production of a range of compounds such as, for example, polyhydroxyalkanoates, pHBA, vanillin, indigo, adipic acid, 2-phenylethanol, 1,3-propane-diol, sorbitol, fructan polymers and lactic acid as well as other products including, inter alia, other plastics, silks, carbohydrates, therapeutic and nutraceutic proteins and antibodies. The present invention further extends to transgenic plants and, in particular, transgenic C4 grass plants, capable of producing the compounds noted above and other products, and to methods for generating such plants. The ability to utilize the high growth rate and efficient carbon fixation of C4 grasses is advantageous, in that it obviates the significant growth penalties observed in other plants, and results in high yields of desired product without necessarily causing concomitant deleterious effects on individual plants. In addition, the C4 grass, sugarcane, is particularly advantageous, as in addition to the features common to all C4 grasses, this plant accumulates sucrose. This sucrose store provides a ready supply of carbon based compounds and energy which may further obviate any deleterious effects on the growth of the plant associated with the production of the product. The present invention provides, therefore, a bioreactor system comprising a genetically modified plant designed to produce particular metabolic or biosynthetic products of interest.

A double-walled vacuum-insulated container for holding a cryogenic fluid comprises a support structure for supporting an inner vessel within an outer vessel. The container has an elongated horizontal axis. A conduit extending between the inner and outer vessels has a wall thickness that allows the conduit to carry a substantial portion of axial loads acting on the inner vessel in a direction parallel to the horizontal axis. The support structure further comprises a non-metallic support spanning between the inner and outer vessels, with the non-metallic support capable of transferring substantially all radial loads transverse to said horizontal axis. The non-metallic support is also fixedly attached to the inner and outer vessels so that it is capable of supporting a substantial portion of the axial loads so that the non-metallic support and the conduit cooperate to provide support in the axial direction.

Antimicrobial compositions for oral delivery, and administration to the colon, distal ileum, or other portion of the gastrointestinal tract other than the stomach, of bacteriophage, phage proteins, antimicrobial peptides, or antimicrobial aptamers, are disclosed. In one embodiment, the active agent is capable of lysing the bacterial cell wall. In another embodiment, the active agent is capable of interacting with a receptor or enzyme in the bacteria. In some embodiments, the active agents selectively act on one or more harmful bacteria, such as Clostridium difficile, and either do not act, or act to a lesser extent, on helpful bacteria, such as bifidobacteria. When the agents are not delivered directly to the colon, they active agents ultimately enter the colon and affect the bacteria that are present in the colon. The compositions can include beads of pectin in the form of a cationic salt enclosing the active agent, or other types of drug delivery systems designed for targeted delivery to the desired portion of the gastrointestinal tract.